Lumithera obtains fda authorization of valeda treatment for dry amd patients to improve vision

Seattle--(business wire)-- #dryamd--lumithera, inc. today announced the u.s. fda has authorized marketing of valeda® light delivery system for patients with dry amd.

AMD Ratings Summary

AMD Quant Ranking